CARLSBAD, Calif. & HOUSTON--(BUSINESS WIRE)--Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for disease research and drug discovery, today announced it has formed a strategic scientific relationship with researchers from Baylor College of Medicine and The University of Texas at Houston, part of the John S. Dunn Gulf Coast Consortium for Chemical Genomics (GCC-CG).
